Longevity and health claims, checked against the actual studies
Peer-reviewed studies, unbiased analysis
Living better, backed by the research.
We turn the peer-reviewed science of longevity, performance, and everyday health into something you can actually use, and we link every claim to the study behind it, so you can check the numbers yourself.
Every study verified on PubMed
Plain English, not clinical
Independent, no industry ties
Latest articles
-
Exercise and Cancer Survival: The CHALLENGE Trial
The first randomized trial of exercise and cancer survival: 80.3% of colon cancer patients stayed cancer-free at five years, against 73.9% given booklets.
-
GLP-1 Microdosing: What the Trials Actually Show
GLP-1 microdosing promises longevity and lower inflammation. No completed trial has tested it, and every dose curve in the real trials runs the other way.
-
FDA Peptides 2026: What the Vote Does Not Mean
The FDA peptides 2026 vote changed no law: no peptide is on the compounding list, FDA’s reviewers proposed keeping them off, and the vote is not binding.
-
Vitamin D Telomeres: What the VITAL Trial Really Found
A VITAL sub-study found vitamin D slowed telomere loss by 140 base pairs in 4 years. The honest read on vitamin D telomeres, and why the marketing overshoots.
-
C15:0 Supplement (Fatty15): What the Evidence Shows
A C15:0 supplement rests on one small trial: 30 young adults, 12 weeks, no weight change. Here is what the fatty15 evidence shows and what food gives you.
-
Organ Age Test: What One Blood Draw Really Shows
An organ age test scores each organ from one blood draw. What 43,616 adults show about brain aging, early death, and why the number is not yet personal.
-
Dog Longevity Drug LOY-002: What the Evidence Shows
No dog longevity drug is approved yet. LOY-002 has cleared two of three FDA sections, and the 1,300-dog trial testing whether it works has not reported.
-
Are the Blue Zones Real? What the Evidence Shows
The blue zones’ habits hold up, but the head counts do not: US birth certificates cut records of people past 110 by 69 to 82 percent. Here is…
-
Klotho Longevity: One Monkey Study, No Human Data
Klotho longevity shots sell for about $25,000 abroad. One low dose helped aged monkeys remember, but no human trial has yet shown a real benefit in people.
-
NAD IV Therapy: What the Evidence Actually Shows
NAD IV therapy costs $200 to $1,000 a session. A 2026 review of 113 studies found zero trials of the drip itself. Here is what the evidence really…
